Alebund Pharmaceuticals
A biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.1b (Public information from Apr 2023)
China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Series A | ||
$60.0m | Series B | ||
$54.5m Valuation: $300m | Series B | ||
* | CNY200m Valuation: CNY5.0b | Series C | |
* | N/A | CNY800m | Debt |
Total Funding | AUD219m |